Amoebiasis is the second leading cause of death from parasitic disease worldwide. The
causative protozoan parasite, Entamoeba histolytica, is a potent pathogen. Secreting …

Amoebiasis is a parasitic disease caused by Entamoeba histolytica (E. histolytica), an
extracellular enteric protozoan. This infection mainly affects people from developing …

The detection of Entamoeba histolytica, the causative agent of amebiasis, is an important
goal of the clinical microbiology laboratory. To assess the scope of E. histolytica infection, it …

Clinical microbiology laboratories need to communicate results of antibacterial susceptibility
testing to prescribers. Sophisticated prescribers who are knowledgeable of the …

The genus Entamoeba contains many species, six of which (Entamoeba histolytica,
Entamoeba dispar, Entamoeba moshkovskii, Entamoeba polecki, Entamoeba coli, and …

Amoebiasis, an enteric protozoan disease caused by Entamoeba histolytica, is a public
health problem in many developing countries, causing up to 100,000 fatal cases annually …

Amebiasis in developed countries is most common in im-migrants and travelers returning
from the third world, and less common in men who have sex with men and …

The epidemiology of amebiasis has dramatically changed since the separation of
Entamoeba histolytica and Entamoeba dispar species, and the worldwide prevalence of …

Amebiasis is one of the great parasitic diseases of human-kind; it predominantly affects
individuals of lower socioeco-nomic status who live in developing countries. Modern …

The neglected tropical diseases (NTDs) represent a group of parasitic and related infectious
diseases such as amebiasis, Chagas disease, cysticercosis, echinococcosis, hookworm …